About
Optimeos Life Sciences develops nanoparticle and microparticle drug delivery platforms to enable targeted, controlled, and efficient delivery of biologics, peptides, RNA, and gene therapies, focusing on rare diseases, immunology, and metabolic disorders.
Explore Optimeos Life Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.